Navigation Links
Hospira to Present at Cowen and Company's 29th Annual Health Care Conference March 17
Date:3/10/2009

LAKE FOREST, Ill., March 10 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), a global specialty pharmaceutical and medication delivery company, today announced that the company will present at Cowen and Company's 29th Annual Health Care Conference on Tuesday, March 17, 2009, at The Boston Marriott Copley Place in Boston.

The presentation is scheduled to begin at 11 a.m. Eastern time on Tuesday, March 17, 2009. It will be available to all interested parties through a live audiocast accessible via the investor relations section of Hospira's Web site at www.hospirainvestor.com. Listeners should log on approximately 10 minutes in advance to ensure proper computer setup to receive the audiocast. The slides accompanying the presentation will be available on the Hospira Web site. A replay of the webcast will be available on the Hospira Web site approximately 24 hours after the live presentation.

About Hospira

Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness(TM). As the world leader in specialty generic injectable pharmaceuticals, Hospira offers one of the broadest portfolios of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions. Through its products, Hospira helps improve the safety, cost and productivity of patient care. The company is headquartered in Lake Forest, Ill., and has more than 14,000 employees. Learn more at www.hospira.com.


'/>"/>
SOURCE Hospira, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Hospira Expands Board of Directors
2. Hospira Reports Fourth-Quarter and Full-Year 2008 Results
3. Hospiras Precedex(R) Phase IV Study Published in the Journal of the American Medical Association
4. Hospira to Host Conference Call for Fourth-Quarter 2008 Results and 2009 Projections
5. Hospira to Present at J.P. Morgans 27th Annual Healthcare Conference January 14
6. Hospira Names Ken Meyers to Lead Human Resources
7. Hospira Reports Third-Quarter 2008 Results
8. Hospira to Present at the 2008 Annual Credit Suisse Health Care Conference on November 12
9. FDA Approves New Indication for Hospiras Precedex (Dexmedetomidine HCL) Injection
10. Hospira Announces New Contracts With Premier Purchasing Partners for Infusion Devices, Solutions And Equipment
11. Hospira Reports Second-Quarter 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... USA; and SHANGHAI, China – , ... ... -- Global public health organization NSF International has certified the ... to NSF/ANSI 53: Drinking Water Treatment Units – Health Effects, ... certification verifies that MicroCeramics’ NanoNose Pitcher Filter System filters the ...
(Date:1/18/2017)... ... January 18, 2017 , ... A Palm Beach doctor plans ... Train, an international charity that provides free surgery to poor children suffering from cleft ... the past I have run to support the efforts of the American Heart Association ...
(Date:1/18/2017)... , ... January 18, 2017 , ... ... asset protection and financial planning services to families and business owners in the ... aimed at supporting children with developmental disabilities. , The Lakemary Center is a ...
(Date:1/18/2017)... ... January 18, 2017 , ... Catalent ... for drugs, biologics and consumer health products, today announced that Mr. Michael Merges, ... upcoming WCBP Conference, to be held at the Mayflower Hotel, Washington DC, on ...
(Date:1/18/2017)... (PRWEB) , ... January 18, 2017 , ... ... of the revolutionary Active Brake Technology (ABT), an innovative braking system that allows ... Active Brake Technology addresses one of the biggest concerns of beginner and intermediate ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... Jan. 18, 2017  Dermata Therapeutics, LLC, a ... treat a variety of dermatological diseases, announces dosing ... in a Phase 2 acne rosacea study. DMT210 ... the proinflammatory cytokines in the skin responsible for ... This clinical trial, DMT210-003, is ...
(Date:1/18/2017)... , January 18, 2017 The report " Automated Breast ... Breast Volume Scanner), By End User (Hospitals, Diagnostic Imaging Centers), Industry Analysis Report, ... Argentina , Germany , UK, ... Russia , China , Japan ... Thailand , Saudi Arabia , UAE, ...
(Date:1/18/2017)... , Jan. 18, 2017  Tarix Orphan LLC today ... granted a Rare Pediatric Disease (RPD) designation for the ... Dystrophic Epidermolysis Bullosa (RDEB), a rare genetic skin disorder. ... treatment is limited to supportive care. "The ... Drug Designation previously granted by the FDA in this ...
Breaking Medicine Technology: